Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACOMITINIB vs DALFAMPRIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACOMITINIB vs DALFAMPRIDINE: Safety Overview

Metric DACOMITINIB DALFAMPRIDINE
Total FAERS Reports 682 56,141
Deaths Reported 325 1,482
Death Rate 47.7% 2.6%
Hospitalizations 168 7,813
Average Patient Age 64.0 yrs 55.9 yrs
% Female Patients 52.0% 73.8%
FDA Approval Date Sep 27, 2018 Jan 22, 2010
Manufacturer Pfizer Laboratories Div Pfizer Inc Accord Healthcare Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription